Find your next paid study

M.D. Anderson Cancer CenterNCT06639854

Actual pay is set by the research site.

Allogeneic Hematopoietic Cell Transplantation

Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Diseases

Alemtuzumab is an antibody that reduces the strength of the immune system that is given in preparation for allogeneic hematopoietic cell transplant (HCT). In t…

Children's Hospital Medical Center, CincinnatiNCT05501756

~$75 – $1,800

Actual pay is set by the research site.

Thrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation

A Phase 2 Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Narsoplimab in Pediatric Patients (28 Days to ≤ 18 Years of Age.) With High-Risk Hematopoietic Stem Cell Transplant Thrombotic Microangiopathy

The purpose of this study is to evaluate the safety and efficacy of narsoplimab in pediatric patients with thrombotic microangiopathies (TMA) following hematop…

Omeros CorporationNCT05855083

~$75 – $2,800

Actual pay is set by the research site.

Hematopoietic and Lymphatic System Neoplasm

A Phase 2, Multicenter, Double-Blind, Randomized, Controlled Trial of the Safety and Immunogenicity of a Self-Amplifying mRNA COVID-19 Vaccine in Adult Hematopoietic Cell Transplant Recipients

This phase IIb trial compares the effect of LUNAR-COV19 vaccine to Comirnaty vaccine in treating adult patients who have received a hematopoietic cell transpla…

Fred Hutchinson Cancer CenterNCT07390968

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

Emapalumab for the Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients

The investigators hypothesize that graft rejection after hematopoietic stem cell transplant (HSCT) is primarily driven by interferon gamma, and prophylactic in…

Hematopoietic Stem Cell TransplantationGraft Failure

Children's Hospital Medical Center, CincinnatiNCT07244419

~$150 – $2,700

Actual pay is set by the research site.

Observational

Development of a Mindfulness-Based Smartphone Application for BMT Caregivers

This pilot study evaluates the feasibility, acceptability, usability, and engagement of a smartphone-delivered mindfulness intervention for caregivers of hemat…

Caregivers of Hematopoietic Stem Cell Transplant (HCT) Patients

H. Lee Moffitt Cancer Center and Research InstituteNCT07352943

Actual pay is set by the research site.

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

This study is being done to establish "normal' values for a new blood test and urine test approach to cancer screening. Patients undergo blood and urine sample…

Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm

Hematopoietic Cell TransplantHematologic Malignancy

Actual pay is set by the research site.

Mayo ClinicNCT06192875

Observational

Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation

Primary PC - or training HCT clinicians to deliver PC domains as part of routine practice - is an alternative model of supportive care. We have developed Senti…

Massachusetts General HospitalNCT06676852

Actual pay is set by the research site.

Wearable Activity Tracking to Curb Hospitalizations (WATCH)

This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before…

Hematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm

University of California, San FranciscoNCT06587100

~$10 – $675

Actual pay is set by the research site.

Outcomes After Chimeric Antigen Receptor Therapy (CAR-T) and Radiation Therapy (RT) for Hematologic Malignancies

This study collects information on outcomes after chimeric antigen receptor therapy and radiation therapy for hematologic malignancies. Collecting information …

Hematopoietic and Lymphoid Cell Neoplasm

M.D. Anderson Cancer CenterNCT04888338

Actual pay is set by the research site.

Phase 1

Pilot Study of Scaling Busulfan Dose to Body Surface Area in Children Undergoing Hematopoietic Stem Cell Transplantation

The goal of this pilot study is to determine if scaling the first busulfan dose to Body Surface Area (BSA) in children with a BSA ≥0.5 m2 and using a BSA-bande…

Busulfan Pharmacokinetic AnalysisBusulfan DosingHematopoietic Stem Cell Transplant (HSCT)+2 more

Children's Hospital of PhiladelphiaNCT07792369

~$150 – $3,000

Actual pay is set by the research site.

ImmunodeficiencyHematopoietic Stem Cell Transplantation

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Background: Allogeneic hematopoietic stem cell transplant involves taking blood stem cells from a donor and giving them to a recipient. The transplants are us…